» Articles » PMID: 17603562

Functional Inhibition of PI3K by the BetaGBP Molecule Suppresses Ras-MAPK Signalling to Block Cell Proliferation

Overview
Journal Oncogene
Date 2007 Jul 3
PMID 17603562
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanisms of signal transduction from cell surface receptors to the interior of the cell are fundamental to the understanding of the role that positive and negative growth factors play in cell physiology and in human diseases. Here, we show that a functional link between phosphatidylinositol-3-OH kinase (PI3K) and Ras is suppressed by the beta-galactoside binding protein (betaGBP) molecule, a cytokine and a negative cell-cycle regulator. Ras-mitogen-activated protein kinase (MAPK) signalling is blocked by betaGBP owing to its ability to inhibit the p110 catalytic subunit of PI3K, whose basal activity is required for Ras activation. Functional inhibition of p110 by betaGBP results in downregulation of PI3K activity, suppression of Ras-GTP loading, consequent loss of MAPK activation and block of cell proliferation. This study sheds light on the molecular mechanisms whereby betaGBP can control cell proliferation and, by extension, may potentially control tumorigenesis by controlling PI3K.

Citing Articles

CRF Receptor Signaling via the ERK1/2-MAP and Akt Kinase Cascades: Roles of Src, EGF Receptor, and PI3-Kinase Mechanisms.

Parra-Mercado G, Fuentes-Gonzalez A, Hernandez-Aranda J, Diaz-Coranguez M, Dautzenberg F, Catt K Front Endocrinol (Lausanne). 2020; 10:869.

PMID: 31920979 PMC: 6921279. DOI: 10.3389/fendo.2019.00869.


Sourcing the immune system to induce immunogenic cell death in Kras-colorectal cancer cells.

Cirone M, Lotti L, Granato M, Di Renzo L, Biunno I, Cattaneo M Br J Cancer. 2019; 121(9):768-775.

PMID: 31558803 PMC: 6889411. DOI: 10.1038/s41416-019-0561-z.


Survival of pancreatic cancer cells lacking KRAS function.

Muzumdar M, Chen P, Dorans K, Chung K, Bhutkar A, Hong E Nat Commun. 2017; 8(1):1090.

PMID: 29061961 PMC: 5653666. DOI: 10.1038/s41467-017-00942-5.


Killing of Kras-mutant colon cancer cells via Rac-independent actin remodeling by the βGBP cytokine, a physiological PI3K inhibitor therapeutically effective in vivo.

Mallucci L, Shi D, Davies D, Jordan P, Nicol A, Lotti L Mol Cancer Ther. 2012; 11(9):1884-93.

PMID: 22752425 PMC: 3439496. DOI: 10.1158/1535-7163.MCT-11-1041-T.


Temporal dissection of K-ras(G12D) mutant in vitro and in vivo using a regulatable K-ras(G12D) mouse allele.

Wang Z, Feng Y, Bardeesy N, Bardessy N, Wong K, Liu X PLoS One. 2012; 7(5):e37308.

PMID: 22606359 PMC: 3350485. DOI: 10.1371/journal.pone.0037308.